Neurotech International Limited (NTI.AX)
AUD 0.03
(13.04%)
AUD 0.03
(13.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1963.00 AUD | -67.06% |
| 2023 | 5959.00 AUD | -84.43% |
| 2022 | 38.26 Thousand AUD | -81.44% |
| 2021 | 206.14 Thousand AUD | 166.45% |
| 2020 | 77.36 Thousand AUD | -60.23% |
| 2019 | 194.55 Thousand AUD | 547.51% |
| 2018 | 30.04 Thousand AUD | -65.98% |
| 2017 | 88.31 Thousand AUD | -30.28% |
| 2016 | 126.66 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | -33.24 Thousand AUD | 0.0% |
| 2024 Q2 | 1507.00 AUD | 0.0% |
| 2024 FY | 1963.00 AUD | -67.06% |
| 2023 FY | 5959.00 AUD | -84.43% |
| 2023 Q2 | 2988.00 AUD | 0.0% |
| 2023 Q4 | 2971.00 AUD | 0.0% |
| 2022 Q2 | 47.73 Thousand AUD | 0.0% |
| 2022 FY | 38.26 Thousand AUD | -81.44% |
| 2022 Q4 | 408.37 Thousand AUD | 0.0% |
| 2021 FY | 206.14 Thousand AUD | 166.45% |
| 2021 Q4 | 175.39 Thousand AUD | 0.0% |
| 2021 Q2 | 30.75 Thousand AUD | 0.0% |
| 2020 Q4 | 40.97 Thousand AUD | 0.0% |
| 2020 FY | 77.36 Thousand AUD | -60.23% |
| 2020 Q2 | 36.38 Thousand AUD | 0.0% |
| 2019 Q2 | 183.85 Thousand AUD | 0.0% |
| 2019 Q4 | 10.7 Thousand AUD | 0.0% |
| 2019 FY | 194.55 Thousand AUD | 547.51% |
| 2018 Q4 | -22.37 Thousand AUD | 0.0% |
| 2018 FY | 30.04 Thousand AUD | -65.98% |
| 2018 Q2 | 52.42 Thousand AUD | 0.0% |
| 2017 Q4 | 48.08 Thousand AUD | 0.0% |
| 2017 Q2 | 40.22 Thousand AUD | 0.0% |
| 2017 FY | 88.31 Thousand AUD | -30.28% |
| 2016 Q2 | 84.51 Thousand AUD | 100.0% |
| 2016 Q1 | 42.25 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | -100.0% |
| 2016 FY | 126.66 Thousand AUD | 0.0% |
| 2016 Q4 | 128.07 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 99.948% |
| Adherium Limited | 840.98 Thousand AUD | 99.767% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 99.997% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 99.952% |
| Anteris Technologies Ltd | 4.11 Million AUD | 99.952% |
| Control Bionics Limited | 5.12 Million AUD | 99.962% |
| CardieX Limited | 10.9 Million AUD | 99.982% |
| Compumedics Limited | 49.71 Million AUD | 99.996% |
| Cochlear Limited | 2.25 Billion AUD | 100.0% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 99.988% |
| Cyclopharm Limited | 27.13 Million AUD | 99.993% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 99.983% |
| Nova Eye Medical Limited | 23.32 Million AUD | 99.992% |
| HeraMED Limited | 402.89 Thousand AUD | 99.513% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | 99.681% |
| ImpediMed Limited | 10.31 Million AUD | 99.981% |
| InhaleRx Limited | 1.2 Million AUD | 99.837% |
| LBT Innovations Limited | 1.25 Million AUD | 99.844% |
| Micro-X Limited | 15.22 Million AUD | 99.987% |
| OncoSil Medical Limited | 1.56 Million AUD | 99.875% |
| PolyNovo Limited | 103.19 Million AUD | 99.998% |
| Respiri Limited | 456.91 Thousand AUD | 99.57% |
| SomnoMed Limited | 91.65 Million AUD | 99.998% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 99.97% |
| Uscom Limited | 3.72 Million AUD | 99.947% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 99.977% |